المؤلفون: Chetwood JD; Department of Gastroenterology and Hepatology, Concord Repatriation General Hospital, Sydney, NSW, Australia.; Concord Clinical School, University of Sydney, Sydney, NSW, Australia., Tran Y; Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Macquarie University, Sydney, NSW, Australia., Subramanian S; Department of Gastroenterology, Cambridge University Hospitals Foundation Trust, Cambridge, UK., Smith PJ; Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Iborra M; Department of Gastroenterology, La Fe University Hospital of Valencia, Valencia, Spain., Buisson A; Service d'Hépato-Gastro Entérologie, 3iHP, INSERM, Centre Hospitalier Universitaire de Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France.; M2iSH, USC-INRA 2018, INSERM U1071, 3iHP, Université Clermont Auvergne, Clermont-Ferrand, France., Paramsothy S; Department of Gastroenterology and Hepatology, Concord Repatriation General Hospital, Sydney, NSW, Australia.; Concord Clinical School, University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia., Leong RW; Department of Gastroenterology and Hepatology, Concord Repatriation General Hospital, Sydney, NSW, Australia.; Concord Clinical School, University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.

المصدر: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Sep 03; Vol. 18 (9), pp. 1440-1449.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN: 1876-4479 (Electronic) Linking ISSN: 18739946 NLM ISO Abbreviation: J Crohns Colitis Subsets: MEDLINE

مواضيع طبية MeSH: Gastrointestinal Agents*/administration & dosage , Gastrointestinal Agents*/adverse effects , Inflammatory Bowel Diseases*/drug therapy , Infliximab*/administration & dosage , Infliximab*/adverse effects, Humans ; Administration, Intravenous/adverse effects ; Crohn Disease/drug therapy ; Injections, Subcutaneous/adverse effects

المؤلفون: Frau T; Hopital Beaujon - Department of Gastroenterology and Nutrition Support APHP, University Paris VII, Clichy, France., El Khatib M; Hopital Beaujon - Department of Gastroenterology and Nutrition Support APHP, University Paris VII, Clichy, France., De Dreuille B; Hopital Beaujon - Department of Gastroenterology and Nutrition Support APHP, University Paris VII, Clichy, France.; Gastrointestinal and Metabolic Dysfunctions in Nutritional Pathologies, Inserm UMR 1149, Centre de Recherche sur l'Inflammation Paris Montmartre, UFR de Médecine Paris Diderot Paris, France., Billiauws L; Hopital Beaujon - Department of Gastroenterology and Nutrition Support APHP, University Paris VII, Clichy, France.; Gastrointestinal and Metabolic Dysfunctions in Nutritional Pathologies, Inserm UMR 1149, Centre de Recherche sur l'Inflammation Paris Montmartre, UFR de Médecine Paris Diderot Paris, France., Nuzzo A; Hopital Beaujon - Department of Gastroenterology and Nutrition Support APHP, University Paris VII, Clichy, France.; Hôpital Bichat, Laboratory for Vascular Translational Science, Paris, France., Joly F; Hopital Beaujon - Department of Gastroenterology and Nutrition Support APHP, University Paris VII, Clichy, France.; Gastrointestinal and Metabolic Dysfunctions in Nutritional Pathologies, Inserm UMR 1149, Centre de Recherche sur l'Inflammation Paris Montmartre, UFR de Médecine Paris Diderot Paris, France.

المصدر: Expert opinion on emerging drugs [Expert Opin Emerg Drugs] 2024 Sep; Vol. 29 (3), pp. 277-288. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101135662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7623 (Electronic) Linking ISSN: 14728214 NLM ISO Abbreviation: Expert Opin Emerg Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Short Bowel Syndrome*/drug therapy , Short Bowel Syndrome*/physiopathology , Gastrointestinal Agents*/pharmacology , Gastrointestinal Agents*/therapeutic use , Gastrointestinal Agents*/administration & dosage , Gastrointestinal Agents*/adverse effects , Peptides*/administration & dosage , Peptides*/pharmacology , Peptides*/therapeutic use , Glucagon-Like Peptide 2*/administration & dosage , Glucagon-Like Peptide 2*/pharmacology, Humans ; Drug Development ; Animals ; Parenteral Nutrition/methods

المؤلفون: Marshanski T; Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petah Tikva, Israel., Fanous E; Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petah Tikva, Israel., Tal N; Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Perets TT; Gastroenterology Laboratory, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.; Department of Digital Medical Technologies, Holon Institute of Technology, Holon, Israel., Matar M; Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Weintraub Y; Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Shamir R; Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Shouval DS; Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

المصدر: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2024 Sep; Vol. 79 (3), pp. 564-572. Date of Electronic Publication: 2024 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8211545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-4801 (Electronic) Linking ISSN: 02772116 NLM ISO Abbreviation: J Pediatr Gastroenterol Nutr Subsets: MEDLINE

مواضيع طبية MeSH: Crohn Disease*/drug therapy , Crohn Disease*/blood , Infliximab*/administration & dosage , Infliximab*/therapeutic use , Gastrointestinal Agents*/administration & dosage , Gastrointestinal Agents*/therapeutic use , Remission Induction*/methods, Humans ; Child ; Retrospective Studies ; Adolescent ; Male ; Female ; Child, Preschool ; Treatment Outcome ; Drug Monitoring/methods ; Dose-Response Relationship, Drug ; Drug Administration Schedule

SCR Disease Name: Pediatric Crohn's disease

المؤلفون: Milioli NJ; Department of Gastroenterology and Gastrointestinal Endoscopy, Pontifical Catholic University of Rio Grande do Sul., Fernandes MV; Department of Gastroenterology and Gastrointestinal Endoscopy, Porto Alegre Health Science's Federal University, Porto Alegre, Brazil., Correa TL; Department of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Antunes V; Department of Gastroenterology and Gastrointestinal Endoscopy, Porto Alegre Health Science's Federal University, Porto Alegre, Brazil., Martins OC; Department of Gastroenterology, Federal University of Juiz de Fora, Juiz de Fora., Florêncio de Mesquita C; Department of Gastroenterology, Federal University of Pernambuco, Recife., Baraldo S; Department of Endoscopy, Barretos Cancer Hospital, Barretos, Brazil., Furfaro F; Department of Gastroenterology and Gastrointestinal Endoscopy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

المصدر: European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2024 Sep 01; Vol. 36 (9), pp. 1068-1074. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review; Review

بيانات الدورية: Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9000874 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5687 (Electronic) Linking ISSN: 0954691X NLM ISO Abbreviation: Eur J Gastroenterol Hepatol Subsets: MEDLINE

مواضيع طبية MeSH: Crohn Disease*/drug therapy , Ustekinumab*/therapeutic use , Antibodies, Monoclonal, Humanized*/therapeutic use , Remission Induction* , Gastrointestinal Agents*/therapeutic use , Gastrointestinal Agents*/adverse effects, Humans ; Treatment Failure ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; Treatment Outcome ; Odds Ratio

المؤلفون: Cucinotta U; Pediatric Gastroenterology and Nutrition, Necker Enfants Malades University Hospital, Paris, France; Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood 'G. Barresi', University of Messina, Messina, Italy. Electronic address: ugocucinotta@gmail.com., Acunzo M; Pediatric Gastroenterology and Nutrition, Necker Enfants Malades University Hospital, Paris, France; Department of Pediatrics, Vittore Buzzi Children's Hospital, Milan, Italy., Payen E; Pediatric Gastroenterology and Nutrition, Necker Enfants Malades University Hospital, Paris, France., Talbotec C; Pediatric Gastroenterology and Nutrition, Necker Enfants Malades University Hospital, Paris, France., Chasport C; Pharmacy, Hopital Universitaire Necker-Enfants Malades, Paris, France., Alibrandi A; Statistical and Mathematical Science Unit, Department of Economics, University of Messina, Messina, Italy., Lacaille F; Pediatric Gastroenterology and Nutrition, Necker Enfants Malades University Hospital, Paris, France., Lambe C; Pediatric Gastroenterology and Nutrition, Necker Enfants Malades University Hospital, Paris, France.

المصدر: The Journal of pediatrics [J Pediatr] 2024 Sep; Vol. 272, pp. 113882. Date of Electronic Publication: 2023 Dec 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0375410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6833 (Electronic) Linking ISSN: 00223476 NLM ISO Abbreviation: J Pediatr Subsets: MEDLINE

مواضيع طبية MeSH: Short Bowel Syndrome*/drug therapy , Short Bowel Syndrome*/economics , Short Bowel Syndrome*/therapy , Peptides*/therapeutic use , Peptides*/economics , Gastrointestinal Agents*/therapeutic use , Gastrointestinal Agents*/economics , Health Care Costs*/statistics & numerical data , Parenteral Nutrition, Home*/economics, Humans ; Retrospective Studies ; Male ; Female ; Child, Preschool ; Child ; Infant ; France

المؤلفون: Heikal OS; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., van Rheenen PF; Department of Paediatric Gastroenterology, Hepatology and Nutrition, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands.; Department of Pharmaceutical Analysis, Groningen Research Institute for Pharmacy, University of Groningen, Groningen, The Netherlands., Kosterink JGW; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands.; Groningen Research Institute of Pharmacy, Pharmacotherapy, Epidemiology & Economics, University of Groningen, Groningen, The Netherlands., Maurer M; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Koomen JV; Department of Anaesthesiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Department of Pharmacology, Toxicology and Kinetics, Dutch Medicines Evaluation Board, Utrecht, The Netherlands., Chelle P; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Mian P; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands.

المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Sep; Vol. 90 (9), pp. 2200-2214. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: Journal Article; Validation Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Infliximab*/pharmacokinetics , Infliximab*/administration & dosage , Infliximab*/therapeutic use , Infliximab*/blood , Bayes Theorem* , Models, Biological* , Gastrointestinal Agents*/pharmacokinetics , Gastrointestinal Agents*/administration & dosage , Gastrointestinal Agents*/blood , Gastrointestinal Agents*/therapeutic use, Humans ; Child ; Adolescent ; Male ; Female ; Inflammatory Bowel Diseases/drug therapy ; Child, Preschool ; Dose-Response Relationship, Drug

المؤلفون: El Hage Chehade N; Department of Internal Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH., Ghoneim S; Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE., Shah S; Department of Internal Medicine, Ronald Reagan Medical Center, University of California Los Angeles, Los Angeles, CA., Pardi DS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN., Farraye FA; Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL., Francis FF; Division of Gastroenterology and Hepatology, American University of Beirut, Beirut, Lebanon.; Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, PA., Hashash JG; Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL.; Division of Gastroenterology and Hepatology, American University of Beirut, Beirut, Lebanon.

المصدر: Journal of clinical gastroenterology [J Clin Gastroenterol] 2024 Sep 01; Vol. 58 (8), pp. 789-799. Date of Electronic Publication: 2024 Sep 01.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7910017 Publication Model: Electronic Cited Medium: Internet ISSN: 1539-2031 (Electronic) Linking ISSN: 01920790 NLM ISO Abbreviation: J Clin Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Colitis, Microscopic*/drug therapy , Adalimumab*/therapeutic use , Adalimumab*/adverse effects , Infliximab*/therapeutic use , Infliximab*/adverse effects , Gastrointestinal Agents*/therapeutic use , Gastrointestinal Agents*/adverse effects , Tumor Necrosis Factor-alpha*/antagonists & inhibitors, Humans ; Treatment Outcome ; Remission Induction

المؤلفون: Kim KO; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea., Lee SH; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.

المصدر: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi [Korean J Gastroenterol] 2024 Aug 25; Vol. 84 (2), pp. 43-50.

نوع المنشور: English Abstract; Review

بيانات الدورية: Publisher: Korean Society of Gastroenterology Country of Publication: Korea (South) NLM ID: 101189416 Publication Model: Print Cited Medium: Internet ISSN: 2233-6869 (Electronic) Linking ISSN: 15989992 NLM ISO Abbreviation: Korean J Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/pharmacology , Biological Products*/therapeutic use , Biological Products*/pharmacology , Gastrointestinal Agents*/therapeutic use , Gastrointestinal Agents*/pharmacology , Inflammatory Bowel Diseases*/drug therapy , Inflammatory Bowel Diseases*/metabolism , Inflammatory Bowel Diseases*/pathology , Integrins*/antagonists & inhibitors , Integrins*/metabolism, Humans

المؤلفون: Gabriëls RY; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., van der Waaij AM; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Linssen MD; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Dobosz M; Department of Oncology and Immuno-Oncology, Regeneron Pharmaceuticals inc, Tarrytown, New York, USA., Volkmer P; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Jalal S; Department of Oncology and Immuno-Oncology, Regeneron Pharmaceuticals inc, Tarrytown, New York, USA., Robinson D; Centre for Optical Diagnostics and Therapy, Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hermoso MA; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.; Laboratory of Innate Immunity, Program of Immunology, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile., Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Festen EAM; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Kats-Ugurlu G; Department of Pathology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Dijkstra G; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., Nagengast WB; Department of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands w.b.nagengast@umcg.nl.

المصدر: Gut [Gut] 2024 Aug 08; Vol. 73 (9), pp. 1454-1463. Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/pharmacokinetics , Gastrointestinal Agents*/pharmacokinetics , Gastrointestinal Agents*/therapeutic use , Gastrointestinal Agents*/administration & dosage , Inflammatory Bowel Diseases*/drug therapy , Inflammatory Bowel Diseases*/pathology , Inflammatory Bowel Diseases*/metabolism , Intestinal Mucosa*/metabolism, Humans ; Female ; Male ; Adult ; Middle Aged ; Fluorescent Dyes ; Molecular Imaging/methods ; Aged ; Dose-Response Relationship, Drug ; Young Adult

المؤلفون: Magro F; Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal.; Department of Gastroenterology, São João Hospital University Centre, Porto, Portugal.; Centre for Health Technology and Services Research, Health Research Network (CINTESIS@RISE), Faculty of Medicine of the University of Porto, Portugal.; Clinical Pharmacology Unit, São João Hospital University Centre, Porto, Portugal.; Portuguese Group of Studies in Inflammatory Bowel Disease (Grupo de Estudos da Doença Inflamatória Intestinal - GEDII), Porto, Portugal., Fernandes S; Department of Gastroenterology, Northern Lisbon University Hospital Centre, Lisbon, Portugal.; Clinica Universitária de Gastrenterologia da Universidade de Medicina de Lisboa, Lisbon, Portugal., Patita M; Department of Gastroenterology, Garcia da Orta Hospital, Almada, Portugal., Arroja B; Department of Gastroenterology, Braga Hospital, Braga, Portugal., Lago P; Portuguese Group of Studies in Inflammatory Bowel Disease (Grupo de Estudos da Doença Inflamatória Intestinal - GEDII), Porto, Portugal.; Department of Gastroenterology, Porto Hospital University Centre, Porto, Portugal., Rosa I; Department of Gastroenterology, IPOLFG, EPE, Lisbon, Portugal., Tavares de Sousa H; Department of Gastroenterology, Algarve Hospital University Centre - Portimão Unit, Portimão, Portugal.; ABC - Algarve Biomedical Center, University of Algarve, Faro, Portugal., Ministro P; Portuguese Group of Studies in Inflammatory Bowel Disease (Grupo de Estudos da Doença Inflamatória Intestinal - GEDII), Porto, Portugal.; Department of Gastroenterology, Viseu-Tondela Hospital Centre, Viseu, Portugal., Mocanu I; Department of Gastroenterology, Garcia da Orta Hospital, Almada, Portugal., Vieira A; Department of Gastroenterology, Garcia da Orta Hospital, Almada, Portugal., Castela J; Department of Gastroenterology, IPOLFG, EPE, Lisbon, Portugal., Moleiro J; Department of Gastroenterology, IPOLFG, EPE, Lisbon, Portugal., Roseira J; Department of Gastroenterology, Algarve Hospital University Centre - Portimão Unit, Portimão, Portugal.; ABC - Algarve Biomedical Center, University of Algarve, Faro, Portugal., Cancela E; Department of Gastroenterology, Viseu-Tondela Hospital Centre, Viseu, Portugal., Sousa P; Department of Gastroenterology, Viseu-Tondela Hospital Centre, Viseu, Portugal., Portela F; Portuguese Group of Studies in Inflammatory Bowel Disease (Grupo de Estudos da Doença Inflamatória Intestinal - GEDII), Porto, Portugal.; Department of Gastroenterology, Coimbra Hospital University Centre, Coimbra, Portugal., Correia L; Portuguese Group of Studies in Inflammatory Bowel Disease (Grupo de Estudos da Doença Inflamatória Intestinal - GEDII), Porto, Portugal.; Department of Gastroenterology, Northern Lisbon University Hospital Centre, Lisbon, Portugal., Moreira P; Clinical Pharmacology Unit, São João Hospital University Centre, Porto, Portugal., Dias S; Portuguese Group of Studies in Inflammatory Bowel Disease (Grupo de Estudos da Doença Inflamatória Intestinal - GEDII), Porto, Portugal., Afonso J; Portuguese Group of Studies in Inflammatory Bowel Disease (Grupo de Estudos da Doença Inflamatória Intestinal - GEDII), Porto, Portugal., Danese S; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IBD Center, Humanitas Research Hospital, IRCCS, Milan, Italy., Peyrin-Biroulet L; Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Nancy, France., Vucicevic KM; Department of Pharmacokinetics and Clinical Pharmacy, University of Belgrade, Serbia., Santiago M; Portuguese Group of Studies in Inflammatory Bowel Disease (Grupo de Estudos da Doença Inflamatória Intestinal - GEDII), Porto, Portugal.

المصدر: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Aug 06; Vol. 18 (7), pp. 1102-1112.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN: 1876-4479 (Electronic) Linking ISSN: 18739946 NLM ISO Abbreviation: J Crohns Colitis Subsets: MEDLINE

مواضيع طبية MeSH: Infliximab*/pharmacokinetics , Disease Progression* , Leukocyte L1 Antigen Complex*/analysis , Inflammatory Bowel Diseases*/drug therapy , Gastrointestinal Agents*/pharmacokinetics , Gastrointestinal Agents*/therapeutic use , Gastrointestinal Agents*/blood, Humans ; Male ; Female ; Prospective Studies ; Adult ; Middle Aged ; Feces/chemistry ; Body Weight ; Colitis, Ulcerative/drug therapy